Evidence map›Paper›PMID 38314428›Full record

ArticleJMA journal2024

Impact of Fish Intake Frequency on Cardiovascular Disease-Specific Survival in Hemodialysis Patients.

Tadasuke Ando, Tomochika Murakami, Sakura Fujiyama, Shin-Ya Sejiyama, Kan Murakami, Daisuke Miki, Yoshitsugu Fujita, Naomichi Yamaguchi, Ryoichi Shirakami, Satoki Abe and 9 more

Open access · diamondAbstract read
In one paragraph

Article in JMA journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 2 countries.

Tadasuke AndoDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Tomochika MurakamiHemodialysis Center, JCHO Nankai Medical Center, Saiki, Japan.
Sakura FujiyamaFaculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Shin-Ya SejiyamaDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Kan MurakamiDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Daisuke MikiHemodialysis Center, JCHO Nankai Medical Center, Saiki, Japan.
Yoshitsugu FujitaHemodialysis Center, JCHO Nankai Medical Center, Saiki, Japan.
Naomichi YamaguchiDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Ryoichi ShirakamiDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Satoki AbeDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Masahiro TodakaDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Shuntaro SuzukiDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Hiroyuki FujinamiDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Mayuka ShinoharaDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Shinro HataDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Toru InoueDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Tadamasa ShibuyaDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Toshitaka ShinDepartment of Urology, Faculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Hiromitsu MimataFaculty of Medicine Graduate School of Medicine, Oita University, Yufu, Japan.
Oita University · JPCardialysis (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cardiovascular disease (CVD) is the leading cause of death in hemodialysis patients (HPs). As a food source, fish contains both CVD-preventive and CVD-promoting fatty acids; however, there is no consensus on fish consumption as a preventive measure for CVD in HPs. This single-center longitudinal cohort study aims to assess the impact of fish intake frequency (FIF) per week on CVD in Japanese HPs. Methods: Upon the initiation of the study, 148 HPs were evaluated to determine the FIF, and blood samples were analyzed. These patients were then monitored for 6 years.The relationships between each FIF and blood sampling data, CVD-specific survival (CSS), and new CVD-free survival (nCFS) were statistically calculated using Kaplan-Meier survival curves. Results: During the observation period, 65 deaths were reported, 16 of which were attributed to CVD. Further, 53 patients developed new CVD onset, and no association was found between the FIF and blood sampling data. Based on the Kaplan-Meier survival curves, there was a significant difference in the CSS probability rates at 72 months between patients with an FIF of ≥4 (0.719, 95% confidence interval (CI): 0.530-0.842) and those with an FIF of ≤3 (0.930, 95% CI: 0.851-0.968) (p < 0.01). However, the nCFS probability at 72 months did not significantly differ between patients with an FIF of ≥4 and those with an FIF of ≤3. Multivariate Cox proportional hazards regression showed that an FIF of ≥4 (hazard ratio: 3.64, 95% CI: 1.22-10.9, p = 0.02) was an independent predictor of CSS, but not of nCFS. Conclusions: It was suggested that a higher FIF in HPs might be one of the risks for developing CVD with increased mortality.

Indexed as

cardiovascular diseasecardiovascular disease-specific survivalfish intake frequencyhemodialysis

Identifiers

PMID38314428
PMCPMC10834181
OpenAlexW4390805687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.